Sr. Director of Global Real Estate and Workplace Strategy at Illumina

San Diego, California, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Life Sciences, GenomicsIndustries

Skills

Key technologies and capabilities for this role

Real Estate StrategyWorkplace StrategySite SelectionFinancial AnalysisLease NegotiationTransaction ManagementPortfolio ManagementCross-Functional LeadershipGlobal Facilities Management

Questions & Answers

Common questions about this position

What is the reporting structure for the Sr. Director of Global Real Estate and Workplace Strategy?

This role reports to the SVP & Head of Global Facilities.

Is this position remote or does it require office presence?

This information is not specified in the job description.

What are the key responsibilities of this role?

The role involves leading global Real Estate and Workplace Strategy Teams, overseeing real estate transactions, supporting expansions and M&A activities, developing multi-year plans, and interacting with executive management.

What is the company culture like at Illumina?

Illumina emphasizes working on impactful projects that transform human health, being surrounded by extraordinary people and inspiring leaders, and having the opportunity to make a difference in a collaborative environment.

What makes a strong candidate for this position?

A strong candidate will have leadership experience in global real estate strategy, skills in transaction negotiations, M&A due diligence, cross-functional collaboration, and the ability to influence executive decisions.

Illumina

Supports genomics startups through funding and resources

About Illumina

Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.

San Diego, CaliforniaHeadquarters

1998Year Founded

$27.2MTotal Funding

IPOCompany Stage

Venture Capital, BiotechnologyIndustries

5,001-10,000Employees

Risks

Over-reliance on NVIDIA's AI technology may limit flexibility in AI solution adoption.

Standardizing proteomics data across platforms could challenge Illumina's data reliability.

Single-flow-cell NovaSeq X System might cannibalize sales of higher-end models.

Differentiation

Illumina leads in genomic sequencing with advanced AI integration and multiomic data analysis.

The company offers innovative array-based solutions for DNA, RNA, and protein analysis.

Illumina's global expansion includes a new Global Capability Center in Bengaluru.

Upsides

Collaboration with NVIDIA enhances drug discovery and clinical development through AI integration.

Pilot proteomics program with UK Biobank aims to generate crucial reference datasets.

Single-cell sequencing kits make high-throughput sequencing accessible to smaller labs.

Land your dream remote job 3x faster with AI

Try Jobo Free